Protection against Omicron re-infection conferred by prior heterologous SARS-CoV-2 infection, with and without mRNA vaccination
Covid19-Sources
Alexandre Freitas on Twitter
Post-acute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases
Studie: Diese Blutgruppe bekommt seltener Covid-19, steckt aber häufiger an
Managing an evolving pandemic: Cryptic circulation of the Delta variant during the Omicron rise
SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma
Perimeter leakage of face masks and its effect on the mask's efficacy
Was ist die Ursache der schweren Hepatitis-Erkrankungen unter Kindern?
EFFECT OF COVID-19 mRNA VACCINES ON SPERM QUALITY
Particle sizes of infectious aerosols: implications for infection control
Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies
Severe Hepatitis in Pediatric COVID-19 - PubMed
Evolution of nasal and olfactory infection characteristics of SARS-CoV-2 variants | bioRxiv
SARS-CoV-2-specific T-cell epitope repertoire in convalescent and mRNA-vaccinated individuals
sigallab.net
North Carolina health officials watch for unusual hepatitis cases in children
SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases - PubMed
COVID-19 mortality preventable by vaccines - Peterson-KFF Health System Tracker
COVID-19 vaccine weekly surveillance reports (weeks 39 to 17, 2021 to 2022)
Philipp S. Holstein on Twitter
COVID-19 Associated Hepatitis in Children (CAH-C) during the second wave of SARS-CoV-2 infections in Central India: Is it a complication or transient phenomenon
Post-COVID‑19-Arthritis. Manifestation unter dem klinischen Bild einer reaktiven Arthritis
Cycle threshold values in symptomatic Covid-19 cases in England
Effects of COVID-19 in Care Homes - A Mixed Methods Review
Safety and immunogenicity of the Pfizer/BioNTech SARS-CoV-2 mRNA third booster vaccine dose against the SARS-CoV-2 BA.1 and BA.2 Omicron variants
Der verkannte Impfstoff
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study
Antigenic evolution will lead to new SARS-CoV-2 variants with unpredictable severity
Jan Hartmann on Twitter